Our Pricing

Understanding Mounjaro Access and Pricing for Evesham Residents

Published: 2 October 2026

Residents searching for Mounjaro Evesham now have access to convenient online prescribing services through UK-registered pharmacies like Cured Pharmacy, where tirzepatide injections start from £124.99 with free clinical assessment. Rather than waiting for in-person appointments or navigating limited local availability, Evesham patients can complete a secure online consultation with GMC-registered prescribers and receive genuine UK-licensed Mounjaro delivered discreetly to their door within 24-48 hours[1]. This service meets the same regulatory standards as high-street pharmacies whilst offering transparent pricing and £20 off your first order with code Weightlossnew.

How Mounjaro Evesham Online Prescribing Works

Accessing Mounjaro Evesham through Cured Pharmacy follows a straightforward clinical pathway designed to meet MHRA and GPhC standards. Patients complete a confidential medical questionnaire covering weight history, existing health conditions, current medications, and contraindications specific to tirzepatide therapy[1]. Our UK-registered prescribers review each assessment individually, typically within 2-4 hours during working days, ensuring the treatment is clinically appropriate before issuing any prescription.

Once approved, Mounjaro is dispensed by our superintendent pharmacist Tarun Kumar (GPhC 2233073) and dispatched via tracked Royal Mail or courier service with full cold-chain integrity maintained throughout transit. Evesham postcodes receive next-day delivery when orders are placed before 3pm on weekdays, with discreet packaging that contains no external pharmacy branding. Follow-up consultations and dose titration guidance are included at no additional cost, supporting patients through the full 12-week escalation protocol recommended in clinical trials[2].

Mounjaro Evesham Pricing and Dosage Options

Cured Pharmacy offers Mounjaro Evesham patients transparent upfront pricing across all five maintenance doses, starting from £124.99 for the 2.5mg starter pen. The tirzepatide dosing schedule begins with 2.5mg subcutaneous injections once weekly for four weeks, escalating every four weeks through 5mg, 7.5mg, 10mg, and up to the maximum licensed dose of 15mg depending on individual response and tolerability[3].

Each Mounjaro KwikPen contains four pre-measured doses, making it a one-month supply at any given strength. Unlike some online providers that bundle multiple months upfront, we allow Evesham patients to purchase one month at a time, providing flexibility to adjust treatment based on efficacy and side effect profile. New patients receive £20 off their first order using code Weightlossnew, reducing the initial 2.5mg starter pack to £124.99.

Comparing Costs Across Treatment Durations

For Mounjaro Evesham patients planning longer treatment courses, understanding cumulative costs helps with budgeting. A typical 12-week titration phase (four weeks each at 2.5mg, 5mg, and 7.5mg) costs approximately £124.99 before any discount codes. Patients reaching the 10mg or 15mg maintenance doses can expect ongoing monthly costs of £124.99 per pen, though many achieve therapeutic goals at lower doses—the SURMOUNT-1 trial showed 89% of participants on 10mg tirzepatide achieved at least 5% body weight reduction[2].

Clinical Evidence Supporting Mounjaro Evesham Prescribing

When Evesham prescribers assess Mounjaro suitability, they reference the robust SURMOUNT clinical trial programme that demonstrated tirzepatide's efficacy in over 5,000 adults with obesity or overweight plus weight-related comorbidities. In the pivotal SURMOUNT-1 study, participants receiving 15mg tirzepatide weekly achieved an average 20.9% body weight reduction over 72 weeks compared to 3.1% with placebo—the largest weight loss observed in any obesity pharmacotherapy trial to date[2].

Mounjaro Evesham patients prescribed the 10mg maintenance dose saw average reductions of 19.5% body weight, with significant improvements in cardiometabolic markers including HbA1c, systolic blood pressure, and lipid profiles[3]. These outcomes inform prescribing decisions for Evesham residents with type 2 diabetes or cardiovascular risk factors, though tirzepatide is licensed in the UK specifically for chronic weight management in adults with BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities[4].

Safety Profile and Common Side Effects

The most frequently reported adverse events in Mounjaro Evesham patients mirror the clinical trial safety data: nausea (25-30% of users), diarrhoea (20-25%), constipation (15-20%), and vomiting (10-15%), typically mild to moderate and diminishing after the first 4-8 weeks of treatment[2]. Our prescribers provide detailed guidance on managing gastrointestinal symptoms through dietary modifications, slower eating pace, and adequate hydration.

Serious adverse events are rare but include potential risks of pancreatitis, gallbladder disease, and hypoglycaemia when combined with insulin or sulfonylureas. Mounjaro carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, contraindicating use in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2[4]. Evesham patients with these risk factors are directed toward alternative weight management options during the clinical assessment.

Mounjaro Evesham Eligibility and Clinical Assessment

To receive a Mounjaro Evesham prescription through Cured Pharmacy, patients must meet specific clinical criteria aligned with UK licensing regulations. Adults aged 18 and over with a current BMI of 30 kg/m² or higher qualify, as do those with BMI 27-29.9 kg/m² who have at least one weight-related comorbidity such as hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease[4].

Our online assessment screens for absolute contraindications including pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, severe gastrointestinal disease, and diabetic ketoacidosis history. Evesham patients taking other GLP-1 receptor agonists or those who have experienced severe allergic reactions to tirzepatide are not suitable candidates. The consultation also evaluates concurrent medications that may interact with Mounjaro, particularly insulin, sulfonylureas, and oral contraceptives where absorption timing may be affected[1].

Delivery and Ongoing Support for Mounjaro Evesham Patients

Mounjaro Evesham deliveries are managed through temperature-controlled logistics that maintain the required 2-8°C storage throughout transit, essential for preserving tirzepatide's stability and efficacy. Each shipment includes insulated packaging with gel packs and a temperature indicator strip, allowing patients to verify the cold chain was maintained. Standard delivery to Evesham postcodes (WR11) takes 24-48 hours from dispatch, with tracking information provided via SMS and email.

Beyond the initial prescription, Mounjaro Evesham patients receive access to ongoing clinical support through Cured Pharmacy's messaging portal and telephone consultation line (+44 116 4646009). Our prescribers monitor treatment response at 4-week intervals, adjusting doses according to the licensed titration schedule and individual tolerance. Patients who experience persistent side effects or inadequate weight loss after 12-16 weeks are reviewed for alternative therapies such as semaglutide (Wegovy) or combination approaches involving dietary programmes[5].

Storage and Administration Guidance

Evesham patients receiving Mounjaro must store unused pens in a refrigerator at 2-8°C, away from the freezer compartment. Once in use, a single pen may be kept at room temperature (not exceeding 30°C) for up to 21 days, convenient for patients who travel or prefer not to inject cold medication. The subcutaneous injection is administered once weekly on the same day each week, rotating between abdomen, thigh, or upper arm sites to minimise injection-site reactions[4]. Our pharmacist-led video tutorials demonstrate proper injection technique, pen operation, and safe disposal of used sharps in an approved container.

Why Choose Cured Pharmacy for Mounjaro Evesham Prescriptions

Cured Pharmacy serves Mounjaro Evesham patients as a fully registered UK pharmacy (GPhC 9012511) operating under the same regulatory framework as traditional high-street pharmacies. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical governance, ensuring every prescription is clinically appropriate, legally compliant, and dispensed with genuine UK-licensed medicines sourced directly from licensed wholesalers[6].

Unlike unregulated online sellers, we require mandatory prescriber review before any tirzepatide supply, protecting patient safety and meeting MHRA standards for prescription-only medicines. Evesham residents benefit from transparent pricing published before consultation (£124.99 per pen), with no hidden fees or compulsory subscription models. Our lowest price guarantee means if you find genuine UK-licensed Mounjaro cheaper elsewhere with equivalent clinical service, we'll match that price. First-time patients Save £20 using code Weightlossnew, and all orders include free delivery, discreet packaging, and unlimited follow-up consultations throughout your treatment journey[1].

Regulatory Assurance and Patient Safety

Every Mounjaro Evesham prescription issued through Cured Pharmacy undergoes review by GMC-registered doctors or independent prescribers with specialist training in obesity medicine and metabolic health. We maintain full audit trails for all consultations, prescriptions, and dispensing records, available for inspection by the General Pharmaceutical Council and Care Quality Commission. Patients can verify our registration status on the GPhC register using our pharmacy number 9012511, and confirm our superintendent pharmacist's credentials through the GPhC registrant search portal[6].

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 2 October 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 2 October 2026]
3. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on glycaemic control and body weight in obesity: SURMOUNT-1 extension. The Lancet, 401(10385), 1393-1404. [accessed 2 October 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for managing overweight and obesity [ID6179]: Final scope. NICE. [accessed 2 October 2026]
5. Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. [accessed 2 October 2026]
6. General Pharmaceutical Council. (2023). Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet. GPhC. [accessed 2 October 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 2 October 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 2 October 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 2 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.